157 related articles for article (PubMed ID: 1562532)
1. Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture.
Mousavi Y; Adlercreutz H
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):615-9. PubMed ID: 1562532
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo.
Saarinen NM; Abrahamsson A; Dabrosin C
Int J Cancer; 2010 Aug; 127(3):737-45. PubMed ID: 19924815
[TBL] [Abstract][Full Text] [Related]
3. Mammalian phytoestrogens: enterodiol and enterolactone.
Wang LQ
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Sep; 777(1-2):289-309. PubMed ID: 12270221
[TBL] [Abstract][Full Text] [Related]
4. Mammalian lignans inhibit the growth of estrogen-independent human colon tumor cells.
Sung MK; Lautens M; Thompson LU
Anticancer Res; 1998; 18(3A):1405-8. PubMed ID: 9673348
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
Lindahl G; Saarinen N; Abrahamsson A; Dabrosin C
Cancer Res; 2011 Jan; 71(1):51-60. PubMed ID: 21097717
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol.
Welshons WV; Murphy CS; Koch R; Calaf G; Jordan VC
Breast Cancer Res Treat; 1987 Nov; 10(2):169-75. PubMed ID: 3427225
[TBL] [Abstract][Full Text] [Related]
7. Role of dietary lignans in the reduction of breast cancer risk.
Saarinen NM; Wärri A; Airio M; Smeds A; Mäkelä S
Mol Nutr Food Res; 2007 Jul; 51(7):857-66. PubMed ID: 17576639
[TBL] [Abstract][Full Text] [Related]
8. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo.
Bergman Jungeström M; Thompson LU; Dabrosin C
Clin Cancer Res; 2007 Feb; 13(3):1061-7. PubMed ID: 17289903
[TBL] [Abstract][Full Text] [Related]
9. Enterolactone has stronger effects than enterodiol on ovarian cancer.
Liu H; Liu J; Wang S; Zeng Z; Li T; Liu Y; Mastriani E; Li QH; Bao HX; Zhou YJ; Wang X; Hu S; Gao S; Qi Y; Shen Z; Wang H; Yu M; Gao T; Johnston RN; Liu SL
J Ovarian Res; 2017 Jul; 10(1):49. PubMed ID: 28738876
[TBL] [Abstract][Full Text] [Related]
10. Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice.
Power KA; Saarinen NM; Chen JM; Thompson LU
Int J Cancer; 2006 Mar; 118(5):1316-20. PubMed ID: 16152607
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20.
Abarzua S; Serikawa T; Szewczyk M; Richter DU; Piechulla B; Briese V
Arch Gynecol Obstet; 2012 Apr; 285(4):1145-51. PubMed ID: 22037685
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignan) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells.
Cosentino M; Marino F; Ferrari M; Rasini E; Bombelli R; Luini A; Legnaro M; Delle Canne MG; Luzzani M; Crema F; Paracchini S; Lecchini S
Pharmacol Res; 2007 Aug; 56(2):140-7. PubMed ID: 17572100
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
14. Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model.
Power KA; Ward WE; Chen JM; Saarinen NM; Thompson LU
Bone; 2006 Jul; 39(1):117-24. PubMed ID: 16469549
[TBL] [Abstract][Full Text] [Related]
15. Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells.
Carreau C; Flouriot G; Bennetau-Pelissero C; Potier M
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):176-85. PubMed ID: 18457947
[TBL] [Abstract][Full Text] [Related]
16. Hydroxymatairesinol and its mammalian metabolite enterolactone reduce the growth and metastasis of subcutaneous AH109A hepatomas in rats.
Miura D; Saarinen NM; Miura Y; Santti R; Yagasaki K
Nutr Cancer; 2007; 58(1):49-59. PubMed ID: 17571967
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
[TBL] [Abstract][Full Text] [Related]
19. Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat.
Saarinen NM; Huovinen R; Wärri A; Mäkelä SI; Valentín-Blasini L; Sjöholm R; Ammälä J; Lehtilä R; Eckerman C; Collan YU; Santti RS
Mol Cancer Ther; 2002 Aug; 1(10):869-76. PubMed ID: 12492120
[TBL] [Abstract][Full Text] [Related]
20. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
